Medeiros, L. Jeffrey; Marques-Piubelli, Mario L.; Sangiorgio, Valentina F. I.; Ruiz-Cordero, Roberto; Vega, Francisco; Feldman, Andrew L.; Chapman, Jennifer R.; Clemens, Mark W.; Hunt, Kelly K.; Evans, Mark G.; Khoo, Christine; Lade, Stephen; Silberman, Mark; Morkowski, Jerzy; Pina, Edward M.; Mills, Daniel C.; Bates, Christopher M.; Magno, Winston B.; Sohani, Aliyah R.; Sieling, Beth A.; O'Donoghue, Joseph M.; Bacon, Chris M.; Patani, Neill; Televantou, Despina; Turner, Suzanne D.; Johnson, Laura; Macneill, Fiona; Wotherspoon, Andrew C.; Iyer, Swaminathan P.; Malpica, Luis E.; Patel, Keyur P.; Xu, Jie; Miranda, Roberto N.

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study

CANCER

IF5.1

2023-11-204

PRE

TROP2 expression in salivary gland adenoid cystic carcinoma (ACC): A new potential therapeutic target for the non-solid subtype

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

OAAI

Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNg-expressing CD8 T cells

CD19 CAR T细胞治疗后的长期血细胞减少与克隆扩增的表达IFNg的CD8 T细胞的骨髓浸润有关

CELL REPORTS MEDICINE

IF10.6

2023-08-0121

OAAI

Strati, Paolo; Li, Xubin; Deng, Qing; Marques-Piubelli, Mario L.; Henderson, Jared; Watson, Grace; Deaton, Laurel; Cain, Taylor; Yang, Haopeng; Ravanmehr, Vida; Fayad, Luis E.; Iyer, Swaminathan P.; Nastoupil, Loretta J.; Hagemeister, Frederick B.; Parra, Edwin R.; Saini, Neeraj; Takahashi, Koichi; Fowler, Nathan H.; Westin, Jason R.; Steiner, Raphael E.; Nair, Ranjit; Flowers, Christopher R.; Wang, Linghua; Ahmed, Sairah; Al-Atrash, Gheath; Vega, Francisco; Neelapu, Sattva S.; Green, Michael R.

CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy

anti-CD30 CAR T细胞治疗后复发的经典霍奇金淋巴瘤中CD30表达经常降低

HISTOPATHOLOGY

IF4.1

2023-03-3010

PRE

PD-L1+ macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

PD-L1巨噬细胞与原发性纵隔 (胸腺) 大b细胞淋巴瘤的有利特征相关

hematology oncology

IF13.5

2023-03-202

OAAI

Pathologic and molecular insights in nodal T-follicular helper cell lymphomas

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-307

OAAI

LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage

MODERN PATHOLOGY

IF5.5

2022-09-019

OAAI

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

多维单细胞分析确定了CD2-CD58相互作用在临床抗肿瘤T细胞反应中的作用

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2022-09-0126

OAAI

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

滤泡性淋巴瘤微环境特征与肿瘤细胞突变及MHC ⅱ 类表达的关系

BLOOD CANCER DISCOVERY

IF11.5

2022-06-1044

OAAI

Han, Guangchun; Deng, Qing; Marques-Piubelli, Mario L.; Dai, Enyu; Dang, Minghao; Ma, Man Chun John; Li, Xubin; Yang, Haopeng; Henderson, Jared; Kudryashova, Olga; Meerson, Mark; Isaev, Sergey; Kotlov, Nikita; Nomie, Krystle J.; Bagaev, Alexander; Parra, Edwin R.; Soto, Luisa M. Solis; Parmar, Simrit; Hagemeister, Fredrick B.; Ahmed, Sairah; Iyer, Swaminathan P.; Samaniego, Felipe; Steiner, Raphael; Fayad, Luis; Lee, Hun; Flower, Nathan H.; Flowers, Christopher R.; Strati, Paolo; Westin, Jason R.; Neelapu, Sattva S.; Nastoupil, Loretta J.; Vega, Francisco; Wang, Linghua; Green, Michael R.

SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

BLOOD ADVANCES

IF7.1

2022-06-026

OAAI

CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma

VIRCHOWS ARCHIV

IF3.1

2022-05-273

PRE

CD70 is a potential target biomarker in peripheral T-cell lymphomas

CD70是外周T细胞淋巴瘤的潜在靶标生物标志物